Replies to post #372212 on Elite Pharmaceuticals Inc (ELTP)

[dr_lowenstein]

and no rational answer was provided, thanks

[jammy32]

I agree that it was a great answer to your question.

[NASDAQ2020]

Elite's Monster Unique second generation IR ADF is 90% cheaper to produce compared to ADFs containing Naltrexone. It can also be used with CNS stimulants to make them abuse deterrent.
The holy grail of IR ADFs trials resume in 2022
Making others obsolete.

Hammer locking the IR ADF market in 2023:
Generic ADT OxyContin is on track to be filed between January 1, 2023 - March 31, 2023. Send us straight to DollarLand !

Patent Pending

Quote Nasrat:

“I am extremely excited about this formulation because it is also a platform that applies to all the IRs and its about 10% of the cost. So we're extremely excited about this, but it's still early, in the next few months once Dr. Smith files a patent and we do a few more trials, we’ll update everyone more about it. “



ELTP

[NASDAQ2020]

The Monsters may be Hungry to get approved.
Maybe a Huge Oxy purchase ?